Envoy Medical Inc. (COCH): Market Cap to Revenue

Symbol and logo of brand Envoy Medical Inc. (COCH)

Envoy Medical, Inc. (COCH) builds lifelong customer loyalty through the surgical installation of implants. Future capital is based on the commercialization of hearing restoration systems that lack external components. The technology's uniqueness lies in the complete absence of batteries, as reflected in the P/S multiple chart. The current 225.80 metric confirms the business valuation level, highlighting the potential of invisible devices that operate around the clock.

COCH Envoy Medical Inc. P/S Multiple (02/21/2024 - 11/16/2026)

Analytical breakdowns for envoymedical.com (COCH)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:COCH Envoy Medical Inc.
Core merchandise of Envoy Medical, Inc.

Envoy Medical, Inc. (COCH) specializes in creating high-tech implants that establish a lifelong client dependency on maintenance services. The P/S ratio compares market capitalization to sales volume, measuring the premium investors are willing to pay per unit of revenue. Analyzing the median P/S allows for the identification of imbalances between market expectations and actual demand for the devices. The stability of this metric confirms the fundamental resilience of a business model characterized by high consumption inertia.

Competitors of Envoy Medical, Inc.

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion, Inc. AORT|P/S Multiple ENOV (enovis.com)|P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (IRADIMED CORPORATION) - Market Cap to Revenue|Embecta Corp. - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Corp) - P/S Multiple|Price to Sales AxoGen Inc AXGN|Price-to-Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Price-to-Revenue Multiple|P/S Multiple BVS (bioventus.com)|P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - P/S Multiple|Price-to-Revenue Coefficient Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Ophthalmic)|Price-to-Revenue Ratio clearpointneuro.com|Market Cap to Revenue Stereotaxis, Inc. (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical - Market Cap to Sales Volume|VANI (Vivani Medical Inc) - Market Cap to Revenue|Market Cap to Revenue Ratio XTNT|NMTC (n1mtc.com) - P/S Multiple|Price to Sales Modular Medical MODD|Price-to-Revenue Ratio myomo.com (MYO)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)